Skip to main content
SpringerLink
Log in

Immunotoxicity of Perfluoroalkylated Compounds

  • Chapter
Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances

Part of the book series: Molecular and Integrative Toxicology ((MOLECUL))

Abstract

The following chapter reports on the health impacts of perfluoroalkylated compounds in the context of in vitro and in vivo immunotoxicology studies as well as epidemiology studies. In general, elevated serum PFAA levels reported in adults and children correlate with observed changes in health to include decreases in serum vaccine titers and IgE levels, or increases in antinuclear antibodies, asthma, the common cold, and gastroenteritis. Laboratory studies demonstrate direct, in vitro effects of perfluorinated compounds modulating TNF-α, IL-6 and IFN-γ. These studies may be linked mechanistically to alterations reporting decreases in vaccine antibody titers in human reports and dose-responsive, decreases in IgM antibody production in animal models. To some extent, perfluoroalkylated compounds are thought to modulate gene regulation via peroxisome proliferator activated receptor alpha (PPARα) and to a lesser extent via peroxisome proliferator activated receptor gamma (PPARγ), yet species differences affecting the expression of this receptor complicates this interpretation as an underlying mechanism in humans. Mechanisms of action beyond PPAR-mediated effects represents new directions and are also discussed. As we learn more about the relationship between perfluoroalkylated compounds and emerging health issues, this may challenge current benchmark thresholds in drinking water to ensure adequate protection for human health.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • 2010/2015 PFOA Stewardship Program|PFOA and Fluorinated Telomers|OPPT|OPPTS|US EPA

    Google Scholar 

  • Andersen ME, Butenhoff JL, Chang S-C, Farrar DG, Kennedy GL et al (2008) Perfluoroalkyl acids and related chemistries–toxicokinetics and modes of action. Toxicol Sci 102:3–14

    Article  CAS  PubMed  Google Scholar 

  • Brieger A, Bienefeld N, Hasan R, Goerlich R, Haase H (2011) Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes. Toxicol In Vitro 25:960–968. doi:10.1016/j.tiv.2011.03.005

    Article  CAS  PubMed  Google Scholar 

  • Burleson FG, Burleson GR (2010) Host resistance assays including bacterial challenge models. Methods Mol Biol 598:97–108. doi:10.1007/978-1-60761-401-2_7

    Article  CAS  PubMed  Google Scholar 

  • Butenhoff JL, Chang S-C, Olsen GW, Thomford PJ (2012) Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology 293:1–15. doi:10.1016/j.tox.2012.01.003

    Article  CAS  PubMed  Google Scholar 

  • Corsini E, Avogadro A, Galbiati V, dell’Agli M, Marinovich M et al (2011) In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). Toxicol Appl Pharmacol 250:108–116. doi:10.1016/j.taap.2010.11.004

    Article  CAS  PubMed  Google Scholar 

  • Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B et al (2012) In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol 258:248–255

    Article  CAS  PubMed  Google Scholar 

  • Corsini E, Luebke RW, Germolec DR, DeWitt JC (2014) Perfluorinated compounds: emerging POPs with potential immunotoxicity. Toxicol Lett 230(2):263–270

    Article  CAS  PubMed  Google Scholar 

  • Costa G, Sartori S, Consonni D (2009) Thirty years of medical surveillance in perfluorooctanoic acid production workers. J Occup Environ Med 51(3):364–372

    Article  CAS  PubMed  Google Scholar 

  • Dewitt JC, Copeland CB, Strynar MJ, Luebke RW (2008) Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect 116:644–650. doi:10.1289/ehp.10896

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D et al (2009) Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39:76–94. doi:10.1080/10408440802209804

    Article  CAS  PubMed  Google Scholar 

  • DeWitt JC, Peden-Adams MM, Keller JM, Germolec DR (2012) Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol 40:300–311. doi:10.1177/0192623311428473

    Article  CAS  PubMed  Google Scholar 

  • Dong G-H, Zhang Y-H, Zheng L, Liu W, Jin Y-H et al (2009) Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch Toxicol 83:805–815. doi:10.1007/s00204-009-0424-0

    Article  CAS  PubMed  Google Scholar 

  • Dong G-H, Liu M-M, Wang D, Zheng L, Liang Z-F et al (2011) Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice. Arch Toxicol 85:1235–1244. doi:10.1007/s00204-011-0661-x

    Article  CAS  PubMed  Google Scholar 

  • Dong G-H, Wang J, Zhang Y-H, Liu M-M, Wang D, Zheng L, Jin Y-H (2012) Induction of p53-mediated apoptosis in splenocytes and thymocytes of C57BL/6 mice exposed to perfluorooctane sulfonate (PFOS). Toxicol Appl Pharmacol 264(2):292–299

    Article  CAS  PubMed  Google Scholar 

  • Dong GH, Tung KY, Tsai CH, Liu MM, Wang D, Liu W, Chen PC, Jin YH, Hsieh WS, Lee YL (2013) Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ Health Perspect 121(4):507

    PubMed Central  Google Scholar 

  • Fei C, McLaughlin JK, Lipworth L, Olsen J (2010) Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res 110:773–777. doi:10.1016/j.envres.2010.08.004

    Article  CAS  PubMed  Google Scholar 

  • Fletcher T, Steenland K, Savitz D (2009) PFOA and immune biomarkers in adults exposed to PFOA in drinking water in the mid Ohio Valley. Status Rep by C8 Sci Panel. Available: http://www.c8sciencepanel.org/pdfs/Status_Report_C8_and_Immune_markers_March2009.pdf

  • Grandjean P, Budtz-Jørgensen E (2013) Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health 12:35. doi:10.1186/1476-069X-12-35

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K et al (2012) Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307:391–397. doi:10.1001/jama.2011.2034

    Article  CAS  PubMed  Google Scholar 

  • Granum B, Haug LS, Namork E, Stølevik SB, Thomsen C, Aaberge IS, van Loveren H, Lovik M, Nygaard UC (2013) Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 10(4):373–379

    Article  CAS  PubMed  Google Scholar 

  • Griesbacher T, Pommer V, Schuligoi R, Tiran B, Peskar B a (2008) Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis. Int Immunopharmacol 8:325–329. doi:10.1016/j.intimp.2007.08.005

    Article  CAS  PubMed  Google Scholar 

  • Guruge KS, Hikono H, Shimada N, Murakami K, Hasegawa J et al (2009) Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. J Toxicol Sci 34:687–691

    Article  CAS  PubMed  Google Scholar 

  • Keil DE, Mehlmann T, Butterworth L, Peden-Adams MM (2008) Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol Sci 103:77–85. doi:10.1093/toxsci/kfn015

    Article  CAS  PubMed  Google Scholar 

  • Kennedy GL, Butenhoff JL, Olsen GW, O’Connor JC, Seacat AM, Perkins RG, Farrar DG (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34(4):351–384

    Article  CAS  PubMed  Google Scholar 

  • Kudo N, Suzuki-Nakajima E, Mitsumoto A, Kawashima Y (2006) Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice: in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol Pharm Bull 29:1952–1957

    Article  CAS  PubMed  Google Scholar 

  • Lefebvre DE, Curran I, Armstrong C, Coady L, Parenteau M et al (2008) Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats. J Toxicol Environ Health A 71:1516–1525. doi:10.1080/15287390802391943

    Article  CAS  PubMed  Google Scholar 

  • Loveless SE, Ladics GS, Smith C, Holsapple MP, Woolhiser MR et al (2007) Interlaboratory study of the primary antibody response to sheep red blood cells in outbred rodents following exposure to cyclophosphamide or dexamethasone. J Immunotoxicol 4:233–238. doi:10.1080/15476910701385687

    Article  CAS  PubMed  Google Scholar 

  • Loveless SE, Hoban D, Sykes G, Frame SR, Everds NE (2008) Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. Toxicol Sci 105:86–96. doi:10.1093/toxsci/kfn113

    Article  CAS  PubMed  Google Scholar 

  • Luster MI, Portier C, Pait DG, White KL, Gennings C et al (1992) Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18:200–210

    Article  CAS  PubMed  Google Scholar 

  • Luster MI, Portier C, Pait DG, Rosenthal GJ, Germolec DR et al (1993) Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam Appl Toxicol 21:71–82

    Article  CAS  PubMed  Google Scholar 

  • Mollenhauer MAM, Bradshaw SG, Fair PA, McGuinn WD, Peden-Adams MM (2011) Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice. J Environ Sci Health A Tox Hazard Subst Environ Eng 46:97–108. doi:10.1080/10934529.2011.532418

    Article  CAS  PubMed  Google Scholar 

  • Okada E, Sasaki S, Saijo Y, Washino N, Miyashita C et al (2012) Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants. Environ Res 112:118–125

    Article  CAS  PubMed  Google Scholar 

  • Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS et al (2008) Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 104:144–154. doi:10.1093/toxsci/kfn059

    Article  CAS  PubMed  Google Scholar 

  • Post GB, Cohn PD, Cooper KR (2012) Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. Environ Res 116:93–117

    Article  CAS  PubMed  Google Scholar 

  • Qazi MR, Bogdanska J, Butenhoff JL, Nelson BD, DePierre JW et al (2009) High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262:207–214. doi:10.1016/j.tox.2009.06.010

    Article  CAS  PubMed  Google Scholar 

  • Qazi MR, Nelson BD, DePierre JW, Abedi-Valugerdi M (2012) High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells in the bone marrow and these effects are partially dependent on reduced food consumption. Food Chem Toxicol 50(9):2955–2963

    Article  CAS  PubMed  Google Scholar 

  • Rosen MB, Schmid JR, Corton JC, Zehr RD, Das KP et al (2010) Gene expression profiling in wild-type and PPARα-null mice exposed to perfluorooctane sulfonate reveals PPARα-independent effects. PPAR Res 2010. doi:10.1155/2010/794739

  • Selgrade MK (1999) Use of immunotoxicity data in health risk assessments: uncertainties and research to improve the process. Toxicology 133:59–72

    Article  CAS  PubMed  Google Scholar 

  • Selgrade MK (2007) Immunotoxicity: the risk is real. Toxicol Sci 100:328–332. doi:10.1093/toxsci/kfm244

    Article  CAS  PubMed  Google Scholar 

  • Starkov AA, Wallace KB (2002) Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci 66:244–252

    Article  CAS  PubMed  Google Scholar 

  • Takacs ML, Abbott BD (2007) Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci 95:108–117. doi:10.1093/toxsci/kfl135

    Article  CAS  PubMed  Google Scholar 

  • Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ (2006) Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X rec. Toxicol Sci 92:476–489. doi:10.1093/toxsci/kfl014

    Article  CAS  PubMed  Google Scholar 

  • Wang I-J, Hsieh W-S, Chen C-Y, Fletcher T, Lien G-W et al (2011) The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. Environ Res 111:785–791

    Article  CAS  PubMed  Google Scholar 

  • White KL, Sheth CM, Peachee VL (2007) Comparison of primary immune responses to SRBC and KLH in rodents. J Immunotoxicol 4:153–158. doi:10.1080/15476910701337688

    Article  PubMed  Google Scholar 

  • Yang Q, Abedi-Valugerdi M, Xie Y, Zhao X-Y, Möller G et al (2002) Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2:389–397

    Article  CAS  PubMed  Google Scholar 

  • Zhang YH, Wang J, Dong GH, Liu MM, Wang D, Zheng L, Jin YH (2013) Mechanism of perfluorooctanesulfonate (PFOS)-induced apoptosis in the immunocyte. J Immunotoxicol 10(1):49–58

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Montana State University, 109 Lewis Hall, Bozeman, MT, 59717, USA

    Deborah E. Keil Ph.D, M.T. (ASCP), D.A.B.T.

Authors
  1. Deborah E. Keil Ph.D, M.T. (ASCP), D.A.B.T.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deborah E. Keil Ph.D, M.T. (ASCP), D.A.B.T. .

Editor information

Editors and Affiliations

  1. Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA

    Jamie C. DeWitt

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Keil, D.E. (2015). Immunotoxicity of Perfluoroalkylated Compounds. In: DeWitt, J. (eds) Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances. Molecular and Integrative Toxicology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-15518-0_10

Download citation

Publish with us

Policies and ethics

Search

Navigation